Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma
The confinement of multiple myeloma (MM) to the bone marrow microenvironment requires an invasive bone marrow biopsy to monitor the malignant compartment. The existing clinical tools used to determine treatment response and tumor relapse are limited in sensitivity mainly because they indirectly meas...
Main Authors: | Sabna Rajeev Krishnan, Frederick Luk, Ross D Brown, Hayley Suen, Yiulam Kwan, Mary Bebawy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558615001566 |
Similar Items
-
Double CD38−/CD138− negative multiple myeloma
by: Vitaliy Mykytiv, et al.
Published: (2019-03-01) -
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device
by: Menachery, Anoop, et al.
Published: (2017) -
THE NEW DIAGNOSTIC FEATURES OF CD138 (SYNDECAN-1) IN MULTIPLE MYELOMA
by: A. F. Karamysheva
Published: (2015-12-01) -
Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.
by: Teresa Paíno, et al.
Published: (2014-01-01) -
Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study
by: Jasmita Dass, et al.
Published: (2019-01-01)